RESUMO
Throughout the last decade, extracellular vesicles (EVs) have become increasingly popular in several areas of regenerative medicine. Recently, Apis mellifera royal jelly EVs (RJ EVs) were shown to display favorable wound healing properties such as stimulation of mesenchymal stem cell migration and inhibition of staphylococcal biofilms. However, the sustained and effective local delivery of EVs in non-systemic approaches - such as patches for chronic cutaneous wounds - remains an important challenge for the development of novel EV-based wound healing therapies. Therefore, the present study aimed to assess the suitability of type I collagen -a well-established biomaterial for wound healing - as a continuous delivery matrix. RJ EVs were integrated into collagen gels at different concentrations, where gels containing 2 mg/ml collagen were found to display the most stable release kinetics. Functionality of released RJ EVs was confirmed by assessing fibroblast EV uptake and migration in a wound healing assay. We could demonstrate reliable EV uptake into fibroblasts with a sustained pro-migratory effect for up to 7 d. Integrating fibroblasts into the RJ EV-containing collagen gel increased the contractile capacity of these cells, confirming availability of RJ EVs to fibroblasts within the collagen gel. Furthermore, EVs released from collagen gels were found to inhibit Staphylococcus aureus ATCC 29213 biofilm formation. Overall, our results suggest that type I collagen could be utilized as a reliable, reproducible release system to deliver functional RJ EVs for wound healing therapies.
Assuntos
Colágeno Tipo I/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Vesículas Extracelulares , Ácidos Graxos/administração & dosagem , Hidrogéis/administração & dosagem , Movimento Celular/efeitos dos fármacos , Movimento Celular/fisiologia , Colágeno Tipo I/síntese química , Relação Dose-Resposta a Droga , Vesículas Extracelulares/química , Ácidos Graxos/síntese química , Fibroblastos/efeitos dos fármacos , Fibroblastos/fisiologia , Humanos , Hidrogéis/síntese químicaRESUMO
Introdução: Existem vários estudos sobre a utilização do pequi (Caryocar brasiliense) no processo cicatricial; contudo, em poucos trabalhos desenvolvidos, avaliou-se resistência dos tecidos à tensão pós-tratamento. Objetivo: Analisar a tensão cicatricial em incisões cutâneas de ratos, após terapia com Caryocar brasiliense. Método: Vinte ratos Wistar, divididos em dois grupos (placebo/tratado), sofreram incisão cutânea no dorso. O grupo tratado recebeu doses diárias de óleo de Caryocar brasiliense, e o placebo aplicação de óleo mineral. Após sacrifício, em sete e quatorze dias pós-cirurgia, amostras de pele foram submetidas à análise tênsil-histológica. Resultados: Observou-se diferença significante intergrupos na força máxima de tração, assim como uma elevação da síntese de colágeno na área das lesões no grupo tratado com óleo Caryocar brasiliense. Conclusão: A terapia com óleo de Caryocar brasiliense aumenta a resistência tênsil da pele, melhorando a resposta reparacional, reduzindo riscos de deiscência e complicações pós-cirúrgicas.
Introduction: There are several studies on the use of Caryocar brasiliense in the scarring process; however, few studies have evaluated posttreatment skin tissue resistance to tension. Objective: To analyze the scar tension in skin incisions of rats after therapy Caryocar brasiliense. Method: Twenty Wistar rats were divided into two groups (placebo / rough) and suffered skin incision in dorso. The treatment group received daily dose of Caryocar brasiliense oil and the placebo group with application of mineral oil. After sacrifice, in seven fourteen days after surgery, skin samples were subjected to tensile-histological analysis. Results: There was a significant intergroup difference in the maximum strength of traction, as well as an increase in collagen synthesis in the area of lesions in the treated group. Conclusion: Treatment with oil from Caryocar brasiliense increases the tensile strength of the skin, improving the healing response and reducing the risks of dehiscence and postoperative complications.